BIONOTE
LIVE

Serial Number

97442977

Owner

Bionote, Inc.

Attorney

CHANGHOON LEE

First Use Date

Jan 10, 2020

Filing Date

Jun 4, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BIONOTE Trademark

Serial Number: 97442977 • Registration: 7589554

BIONOTE is a trademark filed by Bionote, Inc. on June 4, 2022. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Bionote, Inc.

22, Samsung 1-ro 4-gil,

Entity Type: 03

Trademark Details

Filing Date

June 4, 2022

Registration Date

December 3, 2024

First Use Anywhere

January 10, 2020

First Use in Commerce

January 10, 2020

Published for Opposition

January 30, 2024

Goods & Services

(Based on Use in Commerce) Medical diagnostic apparatus for testing for viruses; home virus test kits consisting primarily of medical diagnostic test strips for saliva or nasal discharge analysis, sampling tools being medical swabs, and buffers for use in disease testing; medical and veterinary apparatus for analyzing bacteria in biological samples; medical genetic fragment analyzers for use in the veterinary field; medical genetic analyzer for use in the veterinary field; real-time gene amplification equipment for medical use in the veterinary field; immunological analyzers for medical and veterinary use; medical immunoassay apparatus for use in the veterinary field; medical diagnostic testing instruments for use in immunoassay procedure for use in the veterinary field; immunofluorescence analysis apparatus for medical purposes in the veterinary field; immunoassay apparatus for medical diagnosis in the veterinary field; miniaturized sensors for use in gene analysis and diagnosis for medical and veterinary purposes; medical apparatus for use in treating respiratory, gastrointestinal disease, tropical disease, viral hepatitis, cardiovascular disease, cancer, cytokine or immunoglobulin for use in the veterinary field; medical and veterinary laboratory instruments, namely, clinical chemistry analyzers for medical and veterinary diagnostic use and immunochemistry analyzers for the analysis of biological samples for medical diagnostic use; medical laboratory instruments for performing polymerase chain reaction (PCR) analysis for medical and veterinary diagnostic use; medical devices for use in performing polymerase chain reaction (PCR) for medical and veterinary diagnostic use; apparatus for use in medical analysis, namely, polymerase chain reaction (PCR) instruments for medical and veterinary diagnostic use; medical diagnostic instruments for the analysis of body fluids; apparatus for use in medical diagnostic antigen tests and antibody tests for determining infection with respiratory disease or HIV; (Based on 44(e)) diabetes measuring apparatus, namely, medical and veterinary test kits for diabetes monitoring for home use; glycated hemoglobin measuring apparatus; medical and veterinary diagnostic apparatus for detecting atherosclerosis; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; medical and veterinary diagnostic apparatus for testing for bacteria and viruses; medical and veterinary diagnostic apparatus for testing for viruses in urine; veterinary apparatus and instruments, namely, surgical apparatus and instruments for veterinary use; veterinary apparatus, namely, surgical apparatus and instruments for veterinary use; diagnostic apparatus for the detection of respiratory, gastrointestinal disease, tropical disease, viral hepatitis, cardiovascular disease, cancer, cytokine or immunoglobulin for veterinary use; kidney function test equipment, namely, medical and veterinary diagnostic apparatus for testing kidney functioning; cancer diagnosis measuring apparatus, namely, medical and veterinary apparatus for detecting cancer; genetic testing apparatus for medical and veterinary purposes; electromagnetic medical diagnostic imaging apparatus; genetic testing apparatus for medical purposes; medical ultrasonic diagnostic equipment, namely, medical ultrasound apparatus; pregnancy testing devices, instruments and apparatus, namely, multi-drug testing cups for pregnancy testing purposes; immunoassay apparatus for diagnosis being medical instruments to measure fluorescent immunoassay, serologic test, enzyme-linked immune-specific assay(ELISA), molecular point-of-care (POC) system, automatic blood chemistry analyzer; blood analysis apparatus for diagnosis being medical instruments to measure fluorescent immunoassay, serologic test, enzyme-linked immune-specific assay(ELISA), molecular point-of-care (POC) system, automatic blood chemistry analyzer; ultrasound displaying diagnostic apparatus; devices for measuring blood sugar

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 3, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 13, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 13, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 7, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 4, 2024 AITU
USE AMENDMENT FILED
Aug 2, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 2, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 26, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 26, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 26, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 26, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 26, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 14, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 18, 2023 PBCR
ELECTRONIC RECORD REVIEW COMPLETE
Jul 5, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 30, 2023 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 28, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 28, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 28, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 28, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 28, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 6, 2023 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 6, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 22, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 22, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 27, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 27, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 22, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 14, 2022 NWOS
NEW APPLICATION ENTERED
Jun 8, 2022 NWAP